Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review

Methods report on the development of the 2013 revision and update of the EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria

(2014) T. Zuberbier et al.   ALLERGY

Biologic agents and the therapy of chronic spontaneous urticaria

(2014) Allen P. Kaplan et al.   Current Opinion in Allergy and Clinical Immunology

A Long Term Case Series Study of the Effect of Omalizumab on Chronic Spontaneous Urticaria

(2013) Anna Cecilie Lefévre et al.   Annals of Dermatology

Chronic Spontaneous Urticaria

(2013) Sarbjit S. Saini   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

(2013) Allen Kaplan et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

(2013) Marcus Maurer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria

(2012) Young-Hee Nam et al.   Allergy Asthma & Immunology Research

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

(2011) Sarbjit Saini et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

(2011) Marcus Maurer et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1

(2010) M. Maurer et al.   ALLERGY

The German version of the chronic urticaria quality-of-life questionnaire: factor analysis, validation, and initial clinical findings

(2009) A. Młynek et al.   ALLERGY

Safety and tolerability of omalizumab

(2009) J. Corren et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Treatment of chronic autoimmune urticaria with omalizumab

(2008) Allen P. Kaplan et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY